ECSP972256A - NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES - Google Patents

NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES

Info

Publication number
ECSP972256A
ECSP972256A ECSP972256A ECSP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A EC SP972256 A ECSP972256 A EC SP972256A
Authority
EC
Ecuador
Prior art keywords
prophylaxis
degenerative diseases
pain
diseases
new treatment
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Mervyn Thompson
Neil Upton
Evans John Morris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972256 priority Critical patent/ECSP972256A/en
Publication of ECSP972256A publication Critical patent/ECSP972256A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados y análogos de benzopirano se describen como útiles para el tratamiento y/o la profilaxis de enfermedades degenerativas tales como corea de huntingdon, esquizofrenia, déficits neurológicos asociados con el SIDA, trastornos del sueño(incluidos trastornos del ritmo circadiano, insomnio y narcolepsia), tios por (ejemplo, síndrome de Giles de la Tourette), lesión traumática del cerebro, zumbido, neuralgia, especialmente neuralgia trigémina, dolor neuropático, dolor dental, dolor de cáncer, actividad neuronal inapropiada que resulta en una neurodistesia en enfermedades tales como diabetes, EM y la enfermedad de la neurona motora, ataxias, rigidez muscular (espasmos) y disfunción de la unión temporomandibular.Benzopyran derivatives and analogs are described as useful for the treatment and / or prophylaxis of degenerative diseases such as huntingdon's chorea, schizophrenia, neurological deficits associated with AIDS, sleep disorders (including circadian rhythm disorders, insomnia and narcolepsy), uncles for example (Giles de la Tourette syndrome), traumatic brain injury, tinnitus, neuralgia, especially trigeminal neuralgia, neuropathic pain, dental pain, cancer pain, inappropriate neuronal activity resulting in neurodystesia in diseases such as diabetes, MS and motor neuron disease, ataxias, muscle stiffness (spasms) and dysfunction of the temporomandibular junction.

ECSP972256 1997-09-15 1997-09-15 NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES ECSP972256A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972256 ECSP972256A (en) 1997-09-15 1997-09-15 NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972256 ECSP972256A (en) 1997-09-15 1997-09-15 NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES

Publications (1)

Publication Number Publication Date
ECSP972256A true ECSP972256A (en) 1998-11-30

Family

ID=42043087

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972256 ECSP972256A (en) 1997-09-15 1997-09-15 NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES

Country Status (1)

Country Link
EC (1) ECSP972256A (en)

Similar Documents

Publication Publication Date Title
ES2082887T3 (en) FLUPIRTINE IN COMBINATION WITH ANTIPARKINSONIANS TO COMBAT MUSCULAR SPASMS.
DK1303495T3 (en) Substituted 5-alkylnylpyrimidines with neurotrophic activity
IL225192A (en) Combination of dextromethorphan and quinidine for use in the treatment of mental illness, neuropathic pain or brain injury
DE60324449D1 (en) INHIBITORS OF PHOSPHODIESTERASE OF CYCLIC N, AND THEIR USE IN THERAPY
ATE381935T1 (en) USE OF TRIACETYLURIDINE TO TREAT MITOCHONDRIAL DISEASES
DE69827513D1 (en) ARRANGEMENT FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY INFUSION OF NERVOUS GROWTH FACTORS IN THE BRAIN
EP0970720A3 (en) Treatment of pain and the nervous system
ATE209492T1 (en) USE OF 1,2,4-TRIAZOLO(1,5-C)PYRIMIDINE HETEROCYCLIC ANALOGUE FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS
FI964341A0 (en) Process and equipment for the reduction of adipose tissue in certain parts of the body by combined heat treatment and muscle function
ATE229806T1 (en) ACTIVE SUBSTANCE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CR6620A (en) AMINO BICYCLE ACIDS AS PHARMACEUTICAL AGENTS
GT200000203A (en) COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS.
PL344304A1 (en) Combination therapy for treatment of bipolar disorders
AR008838A1 (en) NEW TREATMENT.
BR0009296A (en) Pharmaceutical composition, processes to induce differentiation of neural cells from target cells, to promote neural activity in an individual, and to prevent or treat disorders and diseases that can be prevented by promoting neural cell differentiation and / or neural activity, and, use a compound
ECSP972256A (en) NEW TREATMENT AND / OR PROPHYLAXIS OF DEGENERATIVE DISEASES
ID23528A (en) THERAPEUTIC TREATMENT FOR SKIN DISORDERS
MXPA00010254A (en) The treatment of sexual dysfunction in certain patient groups.
IL164779A0 (en) Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other oculat disorders
ATE512664T1 (en) COMPOSITION CONTAINING SPHINGOMYELIN FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
AU2003227593A1 (en) New analogs of nitrobenzylthioinosine
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
Daniel ECT seizure duration and alleviation of depression
MY116362A (en) Use of selegiline for the treatment of epileptic disorders
ES1034986Y (en) APPARATUS FOR THE TREATMENT OF THE HUMAN BODY.